Last10K.com

1Life Healthcare Inc (ONEM) SEC Filing 10-Q Quarterly Report for the period ending Thursday, September 30, 2021

SEC Filings

1Life Healthcare Inc

CIK: 1404123 Ticker: ONEM

Exhibit 99.1
One Medical Announces Results for Third Quarter 2021
Third Quarter 2021 Ending Total Membership Count of 715,000, a 40% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 683,000 and At-Risk Membership Count of 32,000
Third Quarter 2021 Net Revenue of $151.3 Million, a 49% Increase Year-Over-Year
Ending Third Quarter 2021 Cash and Short-term Marketable Securities of $590.0 Million
Provides Q4 2021 Guidance and Updates Full Year 2021 Guidance
SAN FRANCISCO – November 3, 2021 – 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced financial results for the third quarter ended September 30, 2021.
“This was an exciting Q3 for One Medical as we welcomed in our new colleagues from Iora and further expanded our services in the senior population; and, as we launched in another new market, Raleigh-Durham, North Carolina,” said Amir Dan Rubin, Chair & CEO of One Medical. “We continue to perform, innovate and grow, as our human-centered and technology-powered model continues to deliver results for a growing number of members, employers and payers, providers, and health networks.”
Financial Highlights for the Third Quarter 2021
All comparisons are to the three months ended September 30, 2020. Unless otherwise noted, our results of operations in this press release include the activity of Iora Health, Inc. ("Iora") beginning from the close of our acquisition on September 1, 2021.
Total membership count as of quarter-end was 715,000 compared to 511,000, a 40% increase; Consumer and Enterprise membership count of 683,000 and At-Risk membership count of 32,000 as of quarter-end.
Net Revenue was $151.3 million compared to $101.7 million, a 49% increase.
Medical Claims Expense Ratio was 87%.
Care Margin was $46.8 million, or 31% of net revenue; Loss from Operations was $72.7 million, or 48% of net revenue.
Adjusted EBITDA was a loss of $6.1 million, or 4% of net revenue; Net Loss was $78.6 million, or 52% of net revenue.
Financial Outlook
One Medical provides forward-looking guidance on membership count, net revenue, Care Margin, and Adjusted EBITDA. Care Margin and Adjusted EBITDA are non-GAAP measures. Guidance includes outlook for Iora beginning from the close of our acquisition on September 1, 2021.


The following information was filed by 1Life Healthcare Inc (ONEM) on Wednesday, November 3, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate 1Life Healthcare Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 1Life Healthcare Inc.

Continue

Assess how 1Life Healthcare Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

1Life Healthcare Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Legal
M & A
Other
Filter Subcategory:
All
Shares
Expense
Product
Cash Flow
Income
Earnings
Debt
Other
Inside 1Life Healthcare Inc's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Comprehensive Loss
Condensed Consolidated Statements Of Operations
Condensed Consolidated Statements Of Redeemable Convertible Preferred Stock And Stockholders' Equity (Deficit)
Condensed Consolidated Statements Of Redeemable Convertible Preferred Stock And Stockholders' Equity (Deficit) (Parenthetical)
Business Combinations
Business Combinations (Tables)
Business Combinations - Acquisition Of Iora, Additional Information (Details)
Business Combinations - Adjustments To Pro Forma Information (Details)
Business Combinations - Intangible Assets Acquired (Details)
Business Combinations - Loan Agreement (Details)
Business Combinations - Other Acquisitions (Details)
Business Combinations - Preliminary Purchase Price Allocation (Details)
Business Combinations - Purchase Price Components (Details)
Business Combinations - Unaudited Pro Forma (Details)
Commitments And Contingencies
Commitments And Contingencies (Details)
Convertible Senior Notes
Convertible Senior Notes (Tables)
Convertible Senior Notes - Additional Information (Details)
Convertible Senior Notes - Summary Of Interest Expense Recognized Related To Convertible Senior Notes (Details)
Convertible Senior Notes - Summary Of Net Carrying Amount Of Liability Component Of Convertible Senior Notes (Details)
Fair Value Measurements And Investments
Fair Value Measurements And Investments (Tables)
Fair Value Measurements And Investments - Additional Information (Details)
Fair Value Measurements And Investments - Investments (Details)
Fair Value Measurements And Investments - Schedule Of Financial Assets And Liabilities Measured At Fair Value On Recurring Basis (Details)
Goodwill And Intangible Assets
Goodwill And Intangible Assets (Tables)
Goodwill And Intangible Assets - Estimated Future Amortization (Details)
Goodwill And Intangible Assets - Goodwill (Details)
Goodwill And Intangible Assets - Intangible Assets And Accumulated Amortization (Details)
Income Taxes
Income Taxes (Details)
Leases
Leases (Tables)
Leases - Additional Information (Details)
Leases - Components Of Operating Lease Costs (Details)
Leases - Future Minimum Lease Payments Under Non-Cancellable Operating Leases (Details)
Leases - Lease Term And Discount Rate (Details)
Leases - Supplemental Cash Flow Information (Details)
Nature Of The Business And Basis Of Presentation
Nature Of The Business And Basis Of Presentation (Tables)
Nature Of The Business And Basis Of Presentation - Additional Information (Details)
Nature Of The Business And Basis Of Presentation - Reconciliation Of Cash, Cash Equivalents And Restricted Cash (Details)
Nature Of The Business And Basis Of Presentation - Summary Of Customers Representing 10% Or More Of Accounts Receivables (Details)
Nature Of The Business And Basis Of Presentation - Summary Of Customers Representing 10% Or More Of Net Revenue (Details)
Net Loss Per Share
Net Loss Per Share (Tables)
Net Loss Per Share - Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share (Details)
Net Loss Per Share - Schedule Of Basic And Diluted Net Loss Per Share (Details)
Note Receivable
Note Receivable (Details)
Related Party Transactions
Revenue Recognition
Revenue Recognition (Tables)
Revenue Recognition - Additional Information (Details)
Revenue Recognition - Capitated Accounts Receivable, Net (Details)
Revenue Recognition - Schedule Of Contract Assets And Deferred Revenue (Details)
Revenue Recognition - Schedule Of Remaining Performance Obligation (Details)
Revenue Recognition - Summary Of Net Patient Service Revenue By Source (Details)
Revenue Recognition - Summary Of Net Revenue (Details)
Stock-Based Compensation
Stock-Based Compensation (Tables)
Stock-Based Compensation - Additional Information (Details)
Stock-Based Compensation - Assumed Equity Awards (Details)
Stock-Based Compensation - Summary Of Rsu Activity (Details)
Stock-Based Compensation - Summary Of Stock Option Activity (Details)
Stock-Based Compensation - Summary Of Stock-Based Compensation Expense (Details)
Stock-Based Compensation - Tranches Of Performance Stock Option (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Variable Interest Entities
Variable Interest Entities (Details)

Material Contracts, Statements, Certifications & more

1Life Healthcare Inc provided additional information to their SEC Filing as exhibits

Ticker: ONEM
CIK: 1404123
Form Type: 10-Q Quarterly Report
Accession Number: 0001404123-21-000086
Submitted to the SEC: Wed Nov 10 2021 4:28:35 PM EST
Accepted by the SEC: Wed Nov 10 2021
Period: Thursday, September 30, 2021
Industry: Offices And Clinics Of Doctors Of Medicine

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/onem/0001404123-21-000086.htm